One study in animals showed that picamilon permeated the [[blood–brain barrier]]<ref name="pmid1884802">{{cite journal | vauthors = Dorofeev BF, Kholodov LE | title = [Pikamilon pharmacokinetics in animals] | language = Russian | journal = Farmakologiia i Toksikologiia | volume = 54 | issue = 2 | pages = 66–9 | year = 1991 | pmid = 1884802 | doi =  }}</ref> and then is [[hydrolyzed]] into GABA and niacin.<ref>{{cite web|url=http://picamilon.org/|title=Technical Description of Picamilon}}</ref> The released GABA in theory would activate [[GABA receptor]]s potentially producing an [[anxiolytic]] response.<ref name="pmid2884549">{{cite journal | vauthors = Shephard RA | title = Behavioral effects of GABA agonists in relation to anxiety and benzodiazepine action | journal = Life Sciences | volume = 40 | issue = 25 | pages = 2429–36 | date = Jun 1987 | pmid = 2884549 | doi = 10.1016/0024-3205(87)90758-2 }}</ref> The second released component, [[niacin]], is a [[vasodilator]].<ref name="pmid17705685">{{cite journal | vauthors = Gille A, Bodor ET, Ahmed K, Offermanns S | title = Nicotinic acid: pharmacological effects and mechanisms of action | journal = Annual Review of Pharmacology and Toxicology | volume = 48 | issue =  | pages = 79–106 | year = 2008 | pmid = 17705685 | doi = 10.1146/annurev.pharmtox.48.113006.094746 }}</ref><ref name="pmid15673472">{{cite journal | vauthors = Prousky J, Seely D | title = The treatment of migraines and tension-type headaches with intravenous and oral niacin (nicotinic acid): systematic review of the literature | journal = Nutrition Journal | volume = 4 | issue =  | pages = 3 | year = 2005 | pmid = 15673472 | pmc = 548511 | doi = 10.1186/1475-2891-4-3 }}</ref>
